verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: teva pharmaceuticals inc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler teva pharmaceuticals inc
Dosage Form CAPSULE, DELAYED RELEASE PELLETS
Routes
ORAL
Active Ingredients

verapamil hydrochloride 360 mg/1

Manufacturer
Teva Pharmaceuticals Inc

Identifiers & Regulatory

Product NDC 0591-2886
Product ID 0591-2886_319554df-fc0d-428a-9799-a352100f1ce9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA019614
Marketing Start 1990-05-29
Marketing End 2026-08-31

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05912886
Hyphenated Format 0591-2886

Supplemental Identifiers

RxCUI
897624
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number NDA019614 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 360 mg/1
source: ndc
Packaging
  • 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (0591-2886-01)
source: ndc

Packages (1)

Ingredients (1)

verapamil hydrochloride (360 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "319554df-fc0d-428a-9799-a352100f1ce9", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897624"], "spl_set_id": ["0742cf97-601b-4c13-a6c3-1a6a616ed292"], "manufacturer_name": ["Teva Pharmaceuticals Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (0591-2886-01)", "package_ndc": "0591-2886-01", "marketing_end_date": "20260831", "marketing_start_date": "19900529"}], "brand_name": "Verapamil Hydrochloride", "product_id": "0591-2886_319554df-fc0d-428a-9799-a352100f1ce9", "dosage_form": "CAPSULE, DELAYED RELEASE PELLETS", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0591-2886", "generic_name": "verapamil hydrochloride", "labeler_name": "Teva Pharmaceuticals Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "360 mg/1"}], "application_number": "NDA019614", "marketing_category": "NDA", "marketing_end_date": "20260831", "marketing_start_date": "19900529"}